MENOPUR Multidose Trockensub 1200 IE c Sol o Tupf
Details
- Manufacturer
- Ferring AG
- ATC code
- G03GA02
- Status
- 9 abgeschlossen
- Reported since
- 183 days
- First report
- 10.11.2022
- Active substance
- menotropinum
- Swissmedic no.
- 6037102
- Product information (AIPS)
- swissmedicinfo.ch →
Overview
MENOPUR Multidose Trockensub 1200 IE c Sol o Tupf is a medication by Ferring AG containing the active substance menotropinum (ATC code G03GA02). This entry is marked as resolved — the documented shortage lasted 183 days. Shortages of this active substance in Switzerland have lasted on average 83 days (measured across 8 historical cases). Switzerland has 17 other products approved with the same active substance — none are currently available.
Available alternatives
No alternatives with the same active substance are currently available.
Composition
Praeparatio cryodesiccata: menotropinum 1200 U.I., lactosum monohydricum, dinatrii phosphas heptahydricus, polysorbatum 20, acidum phosphoricum, pro vitro corresp. natrium max. 0.07 mg. Solvens: metacresolum, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Historical history
This product (or one with the same active substance) has already been 8× in shortage.
Frequently asked questions
What can I do if MENOPUR Multidose Trockensub 1200 IE c Sol o Tupf is unavailable?▾
Contact your pharmacy or treating physician. Substitution with a product containing the same active substance (menotropinum) is often possible. Available alternatives are listed above on this page.
What alternatives exist for MENOPUR Multidose Trockensub 1200 IE c Sol o Tupf?▾
Available alternatives with the same active substance are listed above. menotropinum is the underlying active substance — pharmacies can dispense a generic or alternative brand after consulting with the doctor.
When will MENOPUR Multidose Trockensub 1200 IE c Sol o Tupf be available again?▾
The expected delivery date — if communicated by the manufacturer — is shown in the detail section on this page. Shortages in this active-substance class typically last several weeks in Switzerland. Only the manufacturer can provide a binding forecast.
Why is MENOPUR Multidose Trockensub 1200 IE c Sol o Tupf unavailable?▾
Common reasons include manufacturing problems, active-substance shortages, quality issues, or a planned withdrawal from the Swiss market. More detailed background — when disclosed by the manufacturer — is shown in the detail section above.
Where do I report a shortage of MENOPUR Multidose Trockensub 1200 IE c Sol o Tupf?▾
Shortages are officially reported to drugshortage.ch (by manufacturers and pharmacies). Patients and treating physicians can escalate the shortage through their pharmacy — which has direct access to the reporting pipeline.
Source: drugshortage.ch · no warranty of completeness